These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16873997)

  • 1. Aortic stiffness is an independent determinant of B-type natriuretic peptide in patients with coronary artery disease.
    Sakuragi S; Okawa K; Iwasaki J; Tokunaga N; Kakishita M; Ohe T
    Cardiology; 2007; 107(2):140-6. PubMed ID: 16873997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence and severity of coronary artery disease and changes in B-type natriuretic peptide levels in patients with a normal systolic function.
    Kim BS; Lee HJ; Shin HS; Yoon JH; Lee HY; Kim BJ; Sung KC; Kang JH; Lee MH; Park JR
    Transl Res; 2006 Oct; 148(4):188-95. PubMed ID: 17002921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
    J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aortic stiffness is an independent predictor of left ventricular function in patients with coronary heart disease.
    Sakuragi S; Iwasaki J; Tokunaga N; Hiramatsu S; Ohe T
    Cardiology; 2005; 103(2):107-12. PubMed ID: 15591710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease.
    Nishikimi T; Futoo Y; Tamano K; Takahashi M; Suzuki T; Minami J; Honda T; Uetake S; Asakawa H; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
    Am J Kidney Dis; 2001 Jun; 37(6):1201-8. PubMed ID: 11382689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients.
    Xu Y; Wu Y; Li J; Ma W; Guo X; Luo Y; Hu D
    Hypertens Res; 2008 Jun; 31(6):1079-85. PubMed ID: 18716354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.
    Rogers RK; May HT; Anderson JL; Muhlestein JB
    Am Heart J; 2009 Nov; 158(5):777-83. PubMed ID: 19853697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma BNP levels and left ventricular diastolic function as measured by radionuclide ventriculography in patients with coronary artery disease.
    Celiński R; Cholewiński W; Stefaniak B; Tarkowska A
    Nucl Med Rev Cent East Eur; 2004; 7(2):123-8. PubMed ID: 15968598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.
    Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Bickel C; Lackner KJ; Cambien F; Tiret L; Münzel T; Blankenberg S
    J Am Coll Cardiol; 2006 Feb; 47(3):552-8. PubMed ID: 16458135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation.
    Mehra MR; Uber PA; Potluri S; Ventura HO; Scott RL; Park MH
    Am J Cardiol; 2004 Aug; 94(4):454-8. PubMed ID: 15325928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise-induced changes of B-type natriuretic peptide uncover the unknown coronary artery disease in patients with chest pain and normal left ventricular systolic function.
    Paraskevaidis IA; Tsougos E; Varounis C; Dagres N; Karatzas D; Parissis J; Kremastinos DT
    Eur J Cardiovasc Prev Rehabil; 2011 Feb; 18(1):72-8. PubMed ID: 20485180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a systolic parameter, defined as the ratio of right brachial pre-ejection period to ejection time, on the relationship between brachial-ankle pulse wave velocity and left ventricular diastolic function.
    Hsu PC; Lin TH; Lee CS; Chu CY; Su HM; Voon WC; Lai WT; Sheu SH
    Hypertens Res; 2011 Apr; 34(4):462-7. PubMed ID: 21228788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
    J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximum oxygen uptake at peak exercise in elderly patients with coronary artery disease and preserved left ventricular function: the role of inflammation on top of tissue Doppler-derived systolic and diastolic function.
    Van de Veire NR; De Winter O; Philippé J; De Buyzere M; Bernard D; Langlois M; Gillebert TC; De Sutter J
    Am Heart J; 2006 Aug; 152(2):297.e1-7. PubMed ID: 16875912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function.
    Nishikimi T; Mori Y; Ishimura K; Tadokoro K; Yagi H; Yabe A; Horinaka S; Matsuoka H
    Am J Med; 2004 Apr; 116(8):517-23. PubMed ID: 15063812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central pulse pressure links microalbuminuria with plasma B-type natriuretic peptide elevation: causal implication for cardiorenal syndrome in hypertension.
    Hashimoto J; Ito S
    J Hypertens; 2014 Aug; 32(8):1665-71; discussion 1671. PubMed ID: 24906172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.